Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial

Abstract Background Hearing and vision impairments are highly prevalent in people with dementia and may have a negative impact on quality of life and other dementia-related outcomes. Intervening to optimise sensory impairment and support sensory function may be a means of improving dementia-related...

Full description

Bibliographic Details
Main Authors: Jemma Regan, Eric Frison, Fidéline Collin, Piers Dawes, Mark Hann, Ines Himmelsbach, Emma Hooper, David Reeves, Zoe Simkin, Chryssoula Thodi, Fan Yang, Iracema Leroi, for the SENSE-Cog Trial Development Team
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Trials
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13063-018-2973-0
id doaj-ba112d29555d45fbb1f47623ba87e029
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jemma Regan
Eric Frison
Fidéline Collin
Piers Dawes
Mark Hann
Ines Himmelsbach
Emma Hooper
David Reeves
Zoe Simkin
Chryssoula Thodi
Fan Yang
Iracema Leroi
for the SENSE-Cog Trial Development Team
spellingShingle Jemma Regan
Eric Frison
Fidéline Collin
Piers Dawes
Mark Hann
Ines Himmelsbach
Emma Hooper
David Reeves
Zoe Simkin
Chryssoula Thodi
Fan Yang
Iracema Leroi
for the SENSE-Cog Trial Development Team
Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial
Trials
Dementia
Hearing
Vision
Sensory intervention
Quality of life
Europe
author_facet Jemma Regan
Eric Frison
Fidéline Collin
Piers Dawes
Mark Hann
Ines Himmelsbach
Emma Hooper
David Reeves
Zoe Simkin
Chryssoula Thodi
Fan Yang
Iracema Leroi
for the SENSE-Cog Trial Development Team
author_sort Jemma Regan
title Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial
title_short Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial
title_full Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial
title_fullStr Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial
title_full_unstemmed Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial
title_sort individualised sensory intervention to improve quality of life in people with dementia and their companions (sense-cog trial): study protocol for a randomised controlled trial
publisher BMC
series Trials
issn 1745-6215
publishDate 2019-01-01
description Abstract Background Hearing and vision impairments are highly prevalent in people with dementia and may have a negative impact on quality of life and other dementia-related outcomes. Intervening to optimise sensory impairment and support sensory function may be a means of improving dementia-related outcomes. The SENSE-Cog trial will test whether a home-based multi-part sensory intervention is effective in improving quality of life and other key outcomes in people with dementia and hearing or vision problems (or both) and their companions. Methods This is an European, multi-centre, observer-blind, pragmatic, randomised controlled trial. Three hundred fifty four people with dementia and hearing or vision impairment (or both) and their companions will be randomly assigned to receive either “care as usual” or a multi-component sensory intervention including assessment and correction of hearing or vision impairments (or both), home-based (maximum 10 visits over 18 weeks), therapist-delivered sensory support (that is, adherence to devices; improving the sensory environment (that is, lighting), communication training, and sign-posting to other support agencies). Change from baseline to intervention end (18 weeks) and post-intervention (36 weeks) will be compared between the two arms in the following outcomes: quality of life (primary endpoint), sensory and cognitive functional ability, relationships, mental well-being, health resource utilisation and cost-effectiveness. Discussion This is one of two articles outlining the SENSE-Cog trial. Here, we describe the protocol for the effectiveness of the SENSE-Cog intervention. A parallel and complementary process evaluation will be described elsewhere. If the SENSE-Cog trial demonstrates that the sensory intervention improves outcomes in dementia, we will make a toolkit of training materials, resources and information available to health and social care providers to implement the intervention in routine practice. This will be a significant contribution to the therapeutic management of people with dementia and sensory impairment. Trial registration ISRCTN (Trial ID: ISRCTN17056211) on 19 February 2018.
topic Dementia
Hearing
Vision
Sensory intervention
Quality of life
Europe
url http://link.springer.com/article/10.1186/s13063-018-2973-0
work_keys_str_mv AT jemmaregan individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
AT ericfrison individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
AT fidelinecollin individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
AT piersdawes individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
AT markhann individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
AT ineshimmelsbach individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
AT emmahooper individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
AT davidreeves individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
AT zoesimkin individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
AT chryssoulathodi individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
AT fanyang individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
AT iracemaleroi individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
AT forthesensecogtrialdevelopmentteam individualisedsensoryinterventiontoimprovequalityoflifeinpeoplewithdementiaandtheircompanionssensecogtrialstudyprotocolforarandomisedcontrolledtrial
_version_ 1724865890459058176
spelling doaj-ba112d29555d45fbb1f47623ba87e0292020-11-25T02:21:29ZengBMCTrials1745-62152019-01-0120111510.1186/s13063-018-2973-0Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trialJemma Regan0Eric Frison1Fidéline Collin2Piers Dawes3Mark Hann4Ines Himmelsbach5Emma Hooper6David Reeves7Zoe Simkin8Chryssoula Thodi9Fan Yang10Iracema Leroi11for the SENSE-Cog Trial Development TeamDivision of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences CentreUniversity of Bordeaux, INSERM, EUCLID/F-CRIN Clinical Trials Platform, Bordeaux Population Health Center, CHU BordeauxUniversity of Bordeaux, INSERM, EUCLID/F-CRIN Clinical Trials Platform, Bordeaux Population Health Center, CHU BordeauxManchester Centre for Audiology and Deafness (ManCAD) University of Manchester and the Manchester Academic Health Sciences CentreDivision of Population Health, Health Services Research & Primary Care, University of ManchesterInstitute of Applied Research, Development and Continuing Education, Catholic University of Applied SciencesDivision of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences CentreDivision of Population Health, Health Services Research & Primary Care, University of ManchesterDivision of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences CentreSchool of Sciences, Department of Health Sciences, European University CyprusDivision of Population Health, Health Services Research & Primary Care, University of ManchesterDivision of Neuroscience and Experimental Psychology, University of Manchester and the Manchester Academic Health Sciences CentreAbstract Background Hearing and vision impairments are highly prevalent in people with dementia and may have a negative impact on quality of life and other dementia-related outcomes. Intervening to optimise sensory impairment and support sensory function may be a means of improving dementia-related outcomes. The SENSE-Cog trial will test whether a home-based multi-part sensory intervention is effective in improving quality of life and other key outcomes in people with dementia and hearing or vision problems (or both) and their companions. Methods This is an European, multi-centre, observer-blind, pragmatic, randomised controlled trial. Three hundred fifty four people with dementia and hearing or vision impairment (or both) and their companions will be randomly assigned to receive either “care as usual” or a multi-component sensory intervention including assessment and correction of hearing or vision impairments (or both), home-based (maximum 10 visits over 18 weeks), therapist-delivered sensory support (that is, adherence to devices; improving the sensory environment (that is, lighting), communication training, and sign-posting to other support agencies). Change from baseline to intervention end (18 weeks) and post-intervention (36 weeks) will be compared between the two arms in the following outcomes: quality of life (primary endpoint), sensory and cognitive functional ability, relationships, mental well-being, health resource utilisation and cost-effectiveness. Discussion This is one of two articles outlining the SENSE-Cog trial. Here, we describe the protocol for the effectiveness of the SENSE-Cog intervention. A parallel and complementary process evaluation will be described elsewhere. If the SENSE-Cog trial demonstrates that the sensory intervention improves outcomes in dementia, we will make a toolkit of training materials, resources and information available to health and social care providers to implement the intervention in routine practice. This will be a significant contribution to the therapeutic management of people with dementia and sensory impairment. Trial registration ISRCTN (Trial ID: ISRCTN17056211) on 19 February 2018.http://link.springer.com/article/10.1186/s13063-018-2973-0DementiaHearingVisionSensory interventionQuality of lifeEurope